DK1692517T3 - Anvendelse af ADAM 12 til diagnosticering af præeklampsi - Google Patents

Anvendelse af ADAM 12 til diagnosticering af præeklampsi

Info

Publication number
DK1692517T3
DK1692517T3 DK04790475.0T DK04790475T DK1692517T3 DK 1692517 T3 DK1692517 T3 DK 1692517T3 DK 04790475 T DK04790475 T DK 04790475T DK 1692517 T3 DK1692517 T3 DK 1692517T3
Authority
DK
Denmark
Prior art keywords
adam
diagnosis
eclampsia
preeclampsia
gene products
Prior art date
Application number
DK04790475.0T
Other languages
English (en)
Inventor
Gunnar Wrobel
Peter Angel
Sabine Gack
Marina Schorpp-Kistner
Peter Lichter
Alexander Marme
Susanne Stumm
Original Assignee
Dkfz Krebsforschungszentrum
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dkfz Krebsforschungszentrum filed Critical Dkfz Krebsforschungszentrum
Application granted granted Critical
Publication of DK1692517T3 publication Critical patent/DK1692517T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Reproductive Health (AREA)
  • Pregnancy & Childbirth (AREA)
  • Biophysics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
DK04790475.0T 2003-10-17 2004-10-15 Anvendelse af ADAM 12 til diagnosticering af præeklampsi DK1692517T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03023815A EP1524523A1 (en) 2003-10-17 2003-10-17 Use of ADAM 12 for diagnosis and therapy of preeclampsia
PCT/EP2004/011632 WO2005040831A1 (en) 2003-10-17 2004-10-15 Use of adam 12 for diagnosis and therapy of preeclampsia

Publications (1)

Publication Number Publication Date
DK1692517T3 true DK1692517T3 (da) 2011-09-12

Family

ID=34354513

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04790475.0T DK1692517T3 (da) 2003-10-17 2004-10-15 Anvendelse af ADAM 12 til diagnosticering af præeklampsi

Country Status (6)

Country Link
US (1) US7842464B2 (da)
EP (2) EP1524523A1 (da)
AT (1) ATE465413T1 (da)
DE (1) DE602004026771D1 (da)
DK (1) DK1692517T3 (da)
WO (1) WO2005040831A1 (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE518142T1 (de) 2004-05-19 2011-08-15 Uinv Kobenhavns Adam12 als marker für das turner-syndrom beim fötus
GB0413688D0 (en) * 2004-06-18 2004-07-21 Novartis Forschungsstiftung Analysis of methylated nucleic acid
US7718367B2 (en) * 2005-03-18 2010-05-18 The Chinese University Of Hong Kong Markers for prenatal diagnosis and monitoring
ITTO20050221A1 (it) 2005-04-04 2006-10-05 St Microelectronics Srl Procedimento e sistema per la correzione degli errori a raffica nelle reti di comunicazione, rete e prodotto informatico relativi
WO2007030889A1 (en) * 2005-09-15 2007-03-22 Victor Voroteliak Method of diagnosing pre-eclampsia
US20090274619A1 (en) * 2006-01-26 2009-11-05 George Coukos Tumor vasculature markers and methods of use therof
WO2008119882A2 (en) * 2007-03-30 2008-10-09 Wallac Oy Screening methods based on human adam12 polypeptide and binding agents thereof
CN110187121B (zh) * 2008-10-31 2022-07-01 耶鲁大学 子痫前期检测和治疗的方法和组合物
RU2487657C1 (ru) * 2012-03-01 2013-07-20 Федеральное государственное бюджетное учреждение "Научный центр акушерства, гинекологии и перинатологии имени академика В.И. Кулакова" Министерства здравоохранения и социального развития Российской Федерации" Способ морфологической диагностики преэклампсии
US9582566B2 (en) 2013-12-27 2017-02-28 International Business Machines Corporation Condensing hierarchical data
US9460402B2 (en) * 2013-12-27 2016-10-04 International Business Machines Corporation Condensing hierarchical data
RU2578425C2 (ru) * 2014-05-07 2016-03-27 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Белгородский государственный национальный исследовательский университет" Способ прогнозирования риска развития преэклампсии
CN108717123A (zh) * 2018-04-25 2018-10-30 卢英 一种联合检测sFlt-1/PLGF和HLA-G检测先兆子痫的方法
CN112946299B (zh) * 2021-01-29 2022-11-29 暨南大学 定量ftl的产品在制备子痫前期诊断工具中的应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1250257A1 (ru) * 1985-02-27 1986-08-15 2-Й Московский Ордена Ленина Государственный Медицинский Институт Им.Н.И.Пирогова Способ прогнозировани патологического течени беременности
US5744101A (en) 1989-06-07 1998-04-28 Affymax Technologies N.V. Photolabile nucleoside protecting groups
US6248546B1 (en) * 1998-03-09 2001-06-19 Diagnostic Systems Laboratories, Inc. Assay of IGFBP complex
US20030170627A1 (en) * 2000-11-27 2003-09-11 Walker Michael G. cDNAs co-expressed with placental steroid synthesis genes
WO2003020220A2 (en) 2001-08-30 2003-03-13 Emory University Mitochondrial biology expression arrays
US20040002467A1 (en) 2002-06-29 2004-01-01 Isis Pharmaceuticals Inc. Antisense modulation of ADAM12 expression
ATE518142T1 (de) * 2004-05-19 2011-08-15 Uinv Kobenhavns Adam12 als marker für das turner-syndrom beim fötus
EP1797897A4 (en) * 2004-08-03 2008-06-18 Mochida Pharm Co Ltd MEDICAL COMPOSITION WITH A MELTRINE ANTAGONIST

Also Published As

Publication number Publication date
EP1524523A1 (en) 2005-04-20
US20070161548A1 (en) 2007-07-12
US7842464B2 (en) 2010-11-30
ATE465413T1 (de) 2010-05-15
EP1692517A1 (en) 2006-08-23
WO2005040831A1 (en) 2005-05-06
DE602004026771D1 (de) 2010-06-02
EP1692517B1 (en) 2010-04-21

Similar Documents

Publication Publication Date Title
DK1692517T3 (da) Anvendelse af ADAM 12 til diagnosticering af præeklampsi
EP1750771A4 (en) PANCREATIC ILOT MICRO-RNA AND METHODS OF INHIBITING THE SAME
SG152262A1 (en) Improved modulators of coagulation factors
EP1569695A4 (en) ANTISENSE MODULATION OF APOLIPOPROTEIN B EXPRESSION
SG142154A1 (en) Methods for genomic analysis
CY1110885T1 (el) Πεπτιδια που μπορουν να συνδεθουν στον αυξητικο παραγοντα μεταμορφωσης βητα 1 (tgf-beta1)
EP1409509A4 (en) ANTISENSE MODULATION OF THE EXPRESSION OF C REACTIVE PROTEIN
WO2003008543A3 (en) Antisense modulation of bcl2-associated x protein expression
WO2003105755A3 (en) ANTISENSE MODULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR C (VEGF-C) EXPRESSION
WO2001083513A3 (en) Antisense modulation of inhibitor of dna binding-1 expression
WO2004010956A3 (en) Antisense modulation of lar expression
DE60111620D1 (de) Aktiviertes protein c zur behandlung von pankreatitis
WO2005053728A3 (de) Mit adipositas assoziierte proteine und deren verwendung in therapie und diagnostik
WO2002046367A3 (en) Antisense modulation of cellular apoptosis susceptibility gene expression
WO2004001061A3 (en) Antisense modulation of heme oxygenase 1 expression
HUP0300233A2 (hu) Új növényi promoterok és alkalmazásuk
ATE496129T1 (de) Von hla-klasse-ii-molekülen präsentierte ssx-2- peptide
DE602004030107D1 (de) Suszeptibilitätsgen für die alzheimersche krankheit
WO2003050247A3 (en) Antisense modulation of mhc class ii transactivator expression
WO2003106647A3 (en) ANTISENSE MODULATION OF JUNCTION ADHESION MOLECULE 3 EXPRESSION
WO2003099204A3 (en) Antisense modulation of inhibitor-kappa b kinase-beta expression
WO2004015126A3 (en) Antisense modulation of edg1 expression
DE60109799D1 (de) Verwendung von quetiapin für aufmerksamkeitsmangel-hyperaktivitätsstörungen oder verhaltensstörungen
WO2003105754A3 (en) ANTISENSE MODULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR B (VEGF-B) EXPRESSION
DE60320422D1 (de) Verfahren und formulierungen, die sich für die reduktion des cholesteringehalts von eigelb eignen